These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11327585)

  • 1. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands.
    Van Dort ME; Jung YW
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1045-7. PubMed ID: 11327585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands.
    Van Dort ME; Jung YW
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5285-8. PubMed ID: 15454212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and pharmacological characterization of 4-[4, 4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]- 2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand.
    Van Dort ME; Robins DM; Wayburn B
    J Med Chem; 2000 Aug; 43(17):3344-7. PubMed ID: 10966753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor.
    Teutsch G; Goubet F; Battmann T; Bonfils A; Bouchoux F; Cerede E; Gofflo D; Gaillard-Kelly M; Philibert D
    J Steroid Biochem Mol Biol; 1994 Jan; 48(1):111-9. PubMed ID: 8136296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators.
    Zhang X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5763-6. PubMed ID: 16959487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.
    Parent EE; Dence CS; Jenks C; Sharp TL; Welch MJ; Katzenellenbogen JA
    J Med Chem; 2007 Mar; 50(5):1028-40. PubMed ID: 17328524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.
    Kirkovsky L; Mukherjee A; Yin D; Dalton JT; Miller DD
    J Med Chem; 2000 Feb; 43(4):581-90. PubMed ID: 10691684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production.
    Van Camp JA; Hu LY; Kostlan C; Lefker B; Li J; Mitchell L; Wang Z; Yue WS; Carroll M; Dettling D; Du D; Pocalyko D; Wade K
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5529-32. PubMed ID: 17764935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: relation of their systemic activity to the formation of a common metabolite.
    Cousty-Berlin D; Bergaud B; Bruyant MC; Battmann T; Branche C; Philibert D
    J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):47-55. PubMed ID: 7947350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators.
    Hamann LG; Manfredi MC; Sun C; Krystek SR; Huang Y; Bi Y; Augeri DJ; Wang T; Zou Y; Betebenner DA; Fura A; Seethala R; Golla R; Kuhns JE; Lupisella JA; Darienzo CJ; Custer LL; Price JL; Johnson JM; Biller SA; Zahler R; Ostrowski J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1860-4. PubMed ID: 17292608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity labeling of the androgen receptor with nonsteroidal chemoaffinity ligands.
    Mukherjee A; Kirkovsky LI; Kimura Y; Marvel MM; Miller DD; Dalton JT
    Biochem Pharmacol; 1999 Oct; 58(8):1259-67. PubMed ID: 10487527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists.
    Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Feb; 17(4):955-8. PubMed ID: 17134895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening.
    Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
    Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
    Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral derivatives of 2-cyclohexylideneperhydro-4,7-methanoindenes, a novel class of nonsteroidal androgen receptor ligand: synthesis, X-ray analysis, and biological activity.
    Burden PM; Ai TH; Lin HQ; Akinci M; Costandi M; Hambley TM; Johnston GA
    J Med Chem; 2000 Nov; 43(24):4629-35. PubMed ID: 11101354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
    Yin D; He Y; Perera MA; Hong SS; Marhefka C; Stourman N; Kirkovsky L; Miller DD; Dalton JT
    Mol Pharmacol; 2003 Jan; 63(1):211-23. PubMed ID: 12488554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent androgen antagonists based on carborane as a hydrophobic core structure.
    Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
    J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism.
    Battmann T; Bonfils A; Branche C; Humbert J; Goubet F; Teutsch G; Philibert D
    J Steroid Biochem Mol Biol; 1994 Jan; 48(1):55-60. PubMed ID: 8136306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.